Sotera Health Company today announced the pricing of its initial public offering of 46,600,000 shares of its common stock at a price to the public of $23.00 per share. The gross proceeds of the offering are expected to be approximately $1.1 billion, before deducting underwriting discounts and commissions and offering expenses. The Company has granted the underwriters a 30-day option to purchase up to an additional 6,990,000 shares.

The shares are expected to begin trading on the Nasdaq Global Select Market on November 20, 2020, under the symbol “SHC.” The offering is expected to close on November 24, 2020, subject to customary closing conditions.

J.P. Morgan, Credit Suisse, Goldman Sachs & Co. LLC and Jefferies are acting as joint lead book-running managers and as representatives of the underwriters for the offering. Barclays, Citigroup and RBC Capital Markets are acting as joint book-running managers for the offering. BNP PARIBAS, KeyBanc Capital Markets, Citizens Capital Markets, ING, Academy Securities, Loop Capital Markets, Penserra Securities LLC, Siebert Williams Shank and Tigress Financial Partners are acting as co-managers for the offering.